Dr. Jacob Ijdo received his clinical training at Yale University School of Medicine, where he completed both his Internal Medicine Residency and Rheumatology Fellowship. Post-fellowship, Dr. Ijdo was member of the faculty at the University of Iowa Hospitals and Clinics for 15 years. For the latter part he served as Director of the Rheumatology Fellowship program. In December 2014 Dr. Ijdo moved to Australia, where he became Director of the Rheumatology Department at the Gold Coast University Hospital in Queensland. He was also the Supervisor of Advanced Trainees at Gold Coast University Hospital.
Dr. Ijdo has research interests in the areas of vasculitis and the pathogenesis of tick-borne illness and was awarded an R01 on "Subverted host cell signaling by AnkA in Anaplasma phagocytophilum infection" in 2009. The study investigated the effect of the virulence factor AnkA on host signaling pathways, resulting in inhibition of the respiratory burst and delay of neutrophil apoptosis.
Vasculitis, pathogenesis of tick-borne illness